Petra Frick

Title: Petra Frick: Innovator in Neurodegenerative Disease Research

Introduction

Petra Frick is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and development of pharmaceutical compounds. Her work focuses on inhibiting the aggregation of proteins that are linked to various diseases.

Latest Patents

Petra Frick holds a patent for a drug designed to inhibit the aggregation of proteins involved in diseases associated with protein aggregation and neurodegenerative conditions. The patent describes a compound represented by formula (E) that is intended for use in the treatment or prevention of these diseases. Additionally, it includes pharmaceutical and diagnostic compositions that incorporate the compound, as well as methods for imaging deposits of aggregated proteins. A kit for preparing a detectably labeled compound is also disclosed in her patent.

Career Highlights

Throughout her career, Petra has worked with esteemed institutions such as Ludwig-Maximilians-Universität München and the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. Her research has been pivotal in advancing our understanding of neurodegenerative diseases and developing potential therapeutic solutions.

Collaborations

Petra has collaborated with notable colleagues, including Armin Giese and Uwe Bertsch, who have contributed to her research endeavors and the advancement of her patented technologies.

Conclusion

Petra Frick's innovative work in the field of neurodegenerative diseases highlights her commitment to improving health outcomes through scientific research. Her contributions continue to pave the way for future advancements in the treatment of these challenging conditions.